000 | 01994 a2200565 4500 | ||
---|---|---|---|
005 | 20250516052532.0 | ||
264 | 0 | _c20111129 | |
008 | 201111s 0 0 eng d | ||
022 | _a1552-6259 | ||
024 | 7 |
_a10.1016/j.athoracsur.2011.04.064 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLick, Scott D | |
245 | 0 | 0 |
_aTransplantation of high panel-reactive antibody left ventricular assist device patients without crossmatch using on-bypass pheresis and alemtuzumab. _h[electronic resource] |
260 |
_bThe Annals of thoracic surgery _cOct 2011 |
||
300 |
_a1428-34 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAlemtuzumab |
650 | 0 | 4 |
_aAntibodies _ximmunology |
650 | 0 | 4 |
_aAntibodies, Monoclonal, Humanized _xadministration & dosage |
650 | 0 | 4 |
_aAntibodies, Neoplasm _xadministration & dosage |
650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
650 | 0 | 4 | _aCardiopulmonary Bypass |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 |
_aGraft Rejection _xepidemiology |
650 | 0 | 4 |
_aGraft Survival _ximmunology |
650 | 0 | 4 |
_aHeart Transplantation _ximmunology |
650 | 0 | 4 | _aHeart-Assist Devices |
650 | 0 | 4 | _aHistocompatibility Testing |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIncidence |
650 | 0 | 4 | _aIntraoperative Care |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aPlasmapheresis _xmethods |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 |
_aSurvival Rate _xtrends |
650 | 0 | 4 |
_aTexas _xepidemiology |
650 | 0 | 4 | _aYoung Adult |
700 | 1 | _aBeckles, Daniel L | |
700 | 1 | _aPiovesana, Giovanni | |
700 | 1 | _aVaidya, Smita | |
700 | 1 | _aIndrikovs, Alexander | |
700 | 1 | _aBarbagelata, N Alexander | |
700 | 1 | _aValentine, Vincent | |
773 | 0 |
_tThe Annals of thoracic surgery _gvol. 92 _gno. 4 _gp. 1428-34 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.athoracsur.2011.04.064 _zAvailable from publisher's website |
999 |
_c21099079 _d21099079 |